Characterization of the Pathogenic Features of Multiple SARS-CoV-2 Pandemic Strains in Different Mouse Models
Huize Sun1,2, Kunpeng Liu1,2, Baocheng Yu1,2
1Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China.
Journal of Medical Virology
|November 19, 2024
Summary
New SARS-CoV-2 variants, including Omicron sublineages like EG.5.1, show increased upper respiratory tract and brain infections in mice. Viral infectivity depends on receptor affinity and host immunity, informing strategies against future variants.
Area of Science:
- Virology
- Pathogenesis
- Immunology
Background:
- Understanding emerging SARS-CoV-2 strains is crucial for vaccine and drug development.
- Characterizing viral features in vitro and in vivo aids in predicting and combating viral infections.
Purpose of the Study:
- To comprehensively analyze the virological and pathogenic characteristics of eight SARS-CoV-2 strains, from wild-type to EG.5.1.
- To compare the tropism and pathogenicity of different SARS-CoV-2 variants in various mouse models.
- To investigate the factors influencing viral infectivity, including host receptor affinity and immunocompetence.
Main Methods:
- In vitro virological characterization in Vero E6 cells.
- In vivo pathogenicity studies in K18 hACE2, C57BL/6JGpt, and BKS-db mice.
- Bioinformatic analysis of viral receptor-binding domains (RBDs) and host ACE2 interactions.
Main Results:
- Omicron variants (BA.1 to EG.5.1) demonstrated enhanced upper respiratory tract infection in K18 hACE2 mice.
- XBB.1.9.1 and EG.5.1 showed increased brain tropism, correlating with higher lethality in mice.
- Omicron BA.1, XBB.1.9.1, and EG.5.1 exhibited dual tropism for human and mouse ACE2 receptors.
- Immunocompromised BKS-db mice were more susceptible to Omicron strains than C57BL/6JGpt mice.
Conclusions:
- SARS-CoV-2 variant infectivity is influenced by both viral affinity to host ACE2 and host immunocompetence.
- This study provides a systematic understanding of SARS-CoV-2 pathogenesis in mice.
- Findings offer insights for developing strategies against future SARS-CoV-2 variant surges.


